Shiizaki Kazuhiro, Hatamura Ikuji, Negi Shigeo, Sakaguchi Toshifumi, Saji Fumie, Imazeki Ikuo, Kusano Eiji, Shigematsu Takashi, Akizawa Tadao
Division of Nephrology, Department of Internal Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan.
Nephrol Dial Transplant. 2008 May;23(5):1529-36. doi: 10.1093/ndt/gfm850. Epub 2007 Dec 21.
Controlling hyperplasia of the parathyroid gland (PTG) is important in the management of secondary hyperparathyroidism (SHPT). Regression of the hyperplastic PTG requires a decrease in the number of parathyroid cells (PTCs), so the present study investigated cell death caused by toxic agents or by clinically usable vitamin D metabolites.
The PTGs of Sprague-Dawley rats, which had been 5/6-nephrectomized and fed a high-phosphate diet for 12 weeks, were treated with two consecutive direct injections (DI) of calcitriol, maxacalcitol, paricalcitol, doxercalciferol or phosphate-buffered saline containing either 0.01% or 90% ethanol (0.01-ET or 90-ET, respectively). Laboratory data, including serum levels of intact parathyroid hormone (intact-PTH), were obtained before and after the treatments. The PTGs were excised 24 h after the final injection and evaluated for PTC apoptosis using light and electron microscopy, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling (TUNEL) method and DNA electrophoresis.
Treatment with any of the vitamin D metabolites and 90-ET significantly decreased the serum intact-PTH level, but only the latter significantly decreased the serum Ca level. Either treatment markedly increased the number of TUNEL-positive PTCs, but not in PTG treated with 0.01-ET. In PTGs treated with DI of any vitamin D metabolites was there ladder formation on DNA electrophoresis, as well as the characteristic morphological features of apoptosis in both the light and electron microscopic studies.
DI of vitamin D metabolites may be effective in controlling not only the PTH level, but also PTG hyperplasia, in advanced SHPT by, at least in part, apoptosis-induced cell death. Our study was performed in rats.
控制甲状旁腺(PTG)增生在继发性甲状旁腺功能亢进(SHPT)的管理中至关重要。增生性PTG的消退需要甲状旁腺细胞(PTC)数量减少,因此本研究调查了有毒药物或临床可用的维生素D代谢物引起的细胞死亡。
对Sprague-Dawley大鼠进行5/6肾切除并给予高磷饮食12周,其PTG接受两次连续的直接注射(DI),分别注射骨化三醇、马沙骨化醇、帕立骨化醇、度骨化醇或含0.01%或90%乙醇的磷酸盐缓冲盐水(分别为0.01-ET或90-ET)。在治疗前后获取实验室数据,包括血清完整甲状旁腺激素(intact-PTH)水平。在最后一次注射后24小时切除PTG,使用光学和电子显微镜、末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)法和DNA电泳评估PTC凋亡情况。
用任何一种维生素D代谢物和90-ET治疗均显著降低血清完整PTH水平,但只有后者显著降低血清钙水平。两种治疗均显著增加TUNEL阳性PTC的数量,但0.01-ET治疗的PTG中未增加。在用任何一种维生素D代谢物进行DI治疗的PTG中,DNA电泳出现梯形条带,并且在光学和电子显微镜研究中均有凋亡的特征性形态学特征。
维生素D代谢物的DI可能至少部分通过凋亡诱导的细胞死亡有效控制晚期SHPT中的PTH水平以及PTG增生。我们的研究是在大鼠中进行的。